Projectes destacats

  • Neoadjuvant-adjuvant immunotherapy to improve survival in hepatocellular carcinoma (ASPIRE)

    Investigador/a principal: Josep M. Llovet Bayer.
    Finançador: Asociación Española Contra el Cáncer.
    Durada: 01/04/2024 - 30/06/2030
  • Tumour-host interactions in liver cancer of childhood and adults (THRIVE)

    Investigador/a principal: Josep M. Llovet Bayer.
    Finançador: European Commission.
    Durada: 01/12/2023 - 30/11/2028
  • Programa de Recerca Translacional en Càncer

    Investigador/a principal: Josep M. Llovet Bayer.
    Finançador: Fundació La Caixa.
    Durada: 01/05/2023 - 30/04/2027
  • Identification of biomarkers predicting response and resistance to immunotherapy in advanced hepatocellular carcinoma

    Investigador/a principal: Josep M. Llovet Bayer.
    Finançador: Asociación Española Contra el Cáncer.
    Durada: 01/12/2021 - 30/11/2025
  • Molecular characterization of obesity/diabetes/NASH-related hepatocellular carcinoma

    Investigador/a principal: Josep M. Llovet Bayer.
    Finançador: Agencia Estatal de Investigación.
    Codi: PID2019-105378RB-100.
    Durada: 01/06/2020 - 31/05/2023
  • HUNTER-Hepatocellular Carcinoma Expediter Network

    Investigador/a principal: Josep M. Llovet Bayer.
    Finançador: Asociación Española Contra el Cáncer (AECC).
    Codi: AECC_AccAward17.
    Durada: 01/12/2018 - 30/11/2025
    Resum:

    To decode the immunological landscape of HCC in tissue & blood & lead clinical translation in the community

  • Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co-morbidities

    Investigador/a principal: Josep M. Llovet Bayer.
    Finançador: European Commission.
    Codi: H2020-PHC-2015-2s.
    Durada: 01/01/2016 - 31/12/2019
  • Identification of new drivers as poor prognosis and assessment as therapeutic targets in hepatocellular carcinoma - (DRIVERS-HCC)

    Investigador/a principal: Josep M. Llovet Bayer.
    Finançador: Ministerio de Economia y Competitividad (MINECO).
    Codi: SAF2013-41027-R.
    Durada: 01/01/2014 - 31/07/2017
  • Integrative genomic analysis of human intrahepatic cholangiocarcinoma

    Investigador/a principal: Josep Maria Llovet Bayer.
    Finançador: Asociación Española Contra el Cáncer.
    Codi: AECC_GrupoEstable11.
    Durada: 01/09/2011 - 31/08/2018
  • Genomic predictors and oncogenic drivers in hepatocellular carcinoma

    Investigador/a principal: Josep M. Llovet Bayer.
    Finançador: European Commission.
    Durada: 01/11/2010 - 26/11/2014